Levi & Korsinsky, LLP announces that a AMPE class action lawsuit has been filed on behalf of investors who purchased Ampio Pharmaceuticals, Inc. (AMPE) securities between December 14, 2017 and August 7, 2018. For more on the AMPE Lawsuit please contact us today.
According to the Ampio Pharmaceuticals, Inc. lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that:
(1) the FDA would find Ampio’s AP-003-C Phase 3 clinical trial inadequate and not well-controlled; (2) as a result, Ampio had not successfully completed two pivotal clinical trials for Ampio; (3) consequently, Defendants’ public statements were materially false and misleading at all relevant times.
If you suffered a loss in Ampio Pharmaceuticals, Inc. you have until October 24, 2018 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.